review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0378-4274(99)00212-X |
P698 | PubMed publication ID | 10720775 |
P2093 | author name string | Newby AC | |
P2860 | cites work | Atherosclerosis — An Inflammatory Disease | Q26776972 |
Extracellular matrix and integrin signalling: the shape of things to come | Q28628647 | ||
Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm | Q29547181 | ||
The pathogenesis of atherosclerosis: a perspective for the 1990s | Q29547827 | ||
Endothelial dysfunction in human disease | Q33540187 | ||
Atherosclerotic plaque rupture--pathologic basis of plaque stability and instability | Q33643432 | ||
Strategies to achieve coronary arterial plaque stabilization | Q33643475 | ||
Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells | Q33667974 | ||
A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein | Q33836010 | ||
Nitric oxide and the proliferation of vascular smooth muscle cells | Q33847601 | ||
Atherosclerosis and the arterial smooth muscle cell: Proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis | Q34207431 | ||
Minimally modified low density lipoprotein stimulates monocyte endothelial interactions | Q34248823 | ||
Genetic engineering of vein grafts resistant to atherosclerosis | Q34339752 | ||
Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases | Q34762451 | ||
Hypercholesterolemia increases endothelial superoxide anion production | Q35610616 | ||
Mouse model of venous bypass graft arteriosclerosis | Q35753478 | ||
Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins | Q36376146 | ||
Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability | Q37361893 | ||
Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis. | Q37373677 | ||
The biology of platelet-derived growth factor | Q39502750 | ||
The pathogenesis of atherosclerosis--an update | Q39726917 | ||
Nitric oxide and oxygen radicals: a question of balance | Q40467964 | ||
Molecular bases of the acute coronary syndromes | Q40530238 | ||
Proposed roles for growth factors in mediating smooth muscle proliferation in vascular pathologies | Q40786541 | ||
Factors affecting resistance of low density lipoproteins to oxidation | Q41053329 | ||
Transendothelial transport of low density lipoprotein in association with cell mitosis in rat aorta | Q41350781 | ||
Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins | Q42083643 | ||
Involvement of extracellular-matrix-degrading metalloproteinases in rabbit aortic smooth-muscle cell proliferation | Q42092461 | ||
Vascular endothelial growth factor attenuates leukocyte-endothelium interaction during acute endothelial dysfunction: essential role of endothelium-derived nitric oxide. | Q42472460 | ||
Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. | Q42473074 | ||
Oxidized LDL affects multiple atherogenic cellular responses | Q43519125 | ||
Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits | Q43652291 | ||
Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis | Q44121998 | ||
Initiation of atherosclerotic lesions in cholesterol-fed rabbits. I. Focal increases in arterial LDL concentration precede development of fatty streak lesions. | Q46426029 | ||
Exacerbated transplant arteriosclerosis in inducible nitric oxide-deficient mice | Q48018345 | ||
Vulnerable plaque. Relation of characteristics to degree of stenosis in human coronary arteries. | Q52521021 | ||
Passive Smoking and Impaired Endothelium-Dependent Arterial Dilatation in Healthy Young Adults | Q56428796 | ||
The sequence of cell and matrix changes in atherosclerotic lesions of coronary arteries in the first forty years of life | Q67674363 | ||
Clinical trials of restenosis after coronary angioplasty | Q67962771 | ||
Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine | Q68326802 | ||
Effect of hypercholesterolemia on vascular reactivity in the rabbit. I. Endothelium-dependent and endothelium-independent contractions and relaxations in isolated arteries of control and hypercholesterolemic rabbits | Q68796609 | ||
Porcine coronary arteries with regenerated endothelium have a reduced endothelium-dependent responsiveness to aggregating platelets and serotonin | Q70354268 | ||
Gamma-interferon regulates vascular smooth muscle proliferation and Ia antigen expression in vivo and in vitro | Q70404833 | ||
Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation | Q70580559 | ||
Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta | Q70865443 | ||
An essential role for platelet-derived growth factor in neointima formation in human saphenous vein in vitro | Q71113729 | ||
Angina pectoris and disease progression | Q71730359 | ||
Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors | Q71934600 | ||
Binding of platelet-derived growth factor and low density lipoproteins to glycosaminoglycan species produced by human arterial smooth muscle cells | Q72132398 | ||
Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients | Q72221073 | ||
Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology | Q72708405 | ||
Surgical preparation induces injury and promotes smooth muscle cell proliferation in a culture of human saphenous vein | Q72722204 | ||
Reduced susceptibility of low density lipoprotein (LDL) to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL | Q73112077 | ||
Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basis | Q77124466 | ||
Plaque instability--the real challenge for atherosclerosis research in the next decade? | Q95781246 | ||
P304 | page(s) | 519-529 | |
P577 | publication date | 2000-03-01 | |
P1433 | published in | Toxicology Letters | Q1796854 |
P1476 | title | An overview of the vascular response to injury: a tribute to the late Russell Ross | |
P478 | volume | 112-113 |
Q44111188 | Activation of IP and EP(3) receptors alters cAMP-dependent cell migration |
Q44591584 | Activation of mitogen-activated protein kinases during preparation of vein grafts and modulation by a synthetic inhibitor. |
Q35657503 | Anti-Restenotic Roles of Dihydroaustrasulfone Alcohol Involved in Inhibiting PDGF-BB-Stimulated Proliferation and Migration of Vascular Smooth Muscle Cells |
Q42701304 | Aortic smooth muscle cell alterations in mice systemically exposed to arsenic |
Q55323797 | Atherosclerosis as an inflammatory disease: Doubts? No more. |
Q36333439 | Cells, cytokines and cellular immunity in the pathogenesis of fibroproliferative vasculopathies |
Q35875120 | Development of a mathematical model to describe the transport of monocyte chemoattractant protein-1 through a three-dimensional collagen matrix |
Q34449549 | Dotted collar placed around carotid artery induces asymmetric neointimal lesion formation in rabbits without intravascular manipulations |
Q38020195 | Emerging engineered magnetic nanoparticulate probes for molecular MRI of atherosclerosis: how far have we come? |
Q35440499 | Extended release niacin-laropiprant in patients with hypercholesterolemia or mixed dyslipidemias improves clinical parameters |
Q51626703 | In vitro host response assessment of biomaterials for cardiovascular stent manufacture. |
Q47639140 | Inhibition of 5-Hydroxytryptamine Receptor 2B Reduced Vascular Restenosis and Mitigated the β-Arrestin2-Mammalian Target of Rapamycin/p70S6K Pathway |
Q63240253 | Locally administered antiproliferative drugs inhibit hypercontractility to serotonin in balloon-injured pig coronary artery |
Q37376937 | Niacin: a re-emerging pharmaceutical for the treatment of dyslipidaemia |
Q46743103 | Oxidized LDL stimulates lipid peroxidation-derived DNA and protein adducts in human vascular endothelial and smooth muscle cells |
Q79353325 | Smooth muscle cell proliferation but not neointimal formation is dependent on alloantibody in a murine model of intimal hyperplasia |
Q53440350 | Surface grafting of blood compatible zwitterionic poly(ethylene glycol) on diamond-like carbon-coated stent. |
Q30475323 | Ultrasound-mediated delivery of echogenic immunoliposomes to porcine vascular smooth muscle cells in vivo |
Q44574805 | Ultrastructural evidence of early endothelial damage in coronary arteries of rat cardiac allografts. |
Q37376682 | Vascular wall resident progenitor cells: a review |
Search more.